Submitted by Anonymous (not verified) on 15 October 2025 - 15:05
Human medicines European public assessment report (EPAR): Simponi, golimumab, Date of authorisation: 01/10/2009, Revision: 52, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Simponi, golimumab, Date of authorisation: 01/10/2009, Revision: 52, Status: Authorised